REGENERON PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q4 2023.
  • Regeneron Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $78M, a 9.55% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $78M +$6.8M +9.55% Dec 31, 2023 10-K 2024-02-05
Q4 2022 $71.2M Dec 31, 2022 10-K 2024-02-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.